Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-02-25 @ 4:49 PM
Study NCT ID:
NCT02166658
Status:
TERMINATED
Last Update Posted:
2018-01-23
First Post:
2014-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)
Sponsor:
AIO-Studien-gGmbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AIO-ZNS-0113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None